Controlling the Global HIV and TB Epidemics:  Challenges and Opportunities
Co-Hosted by the Pennsylvania Drug Discovery Institute

Emilio A. Emini, Ph.D.

Emilio A. Emini, Ph.D. is the Director of the Tuberculosis and HIV Program at the Bill and Melinda Gates Foundation.  In this role, Emilio leads the foundation’s efforts to control the global TB and HIV epidemics.  He joined the foundation as Director of the HIV program in 2015 and integrated the TB and HIV programs in 2018.  Following a postdoctoral fellowship, Emilio joined the Merck Research Laboratories in 1983.  Over the following years, he led the biological research that resulted in the development of one of the first highly active antiretroviral therapies for the treatment of HIV infection. In 1997, Emilio moved from his position as Executive Director of Antiviral Research to become Merck’s Vice President of Vaccine Research. In this role, he led the research team that participated in the successful development of multiple pediatric and adolescent vaccines, including the human papillomavirus and rotavirus vaccines.  In 2004, Emilio joined the International AIDS Vaccine Initiative as Senior Vice President of Vaccine Development.  Prior to his current role and beginning in 2005, Emilio served as Senior Vice President of Vaccine Research and Development at Pfizer Inc. where he led the R&D program that resulted in the development of the Prevenar 13 vaccine for the prevention of pneumococcal disease. Emilio is a recipient of the Distinguished Alumnus Award from the Cornell University Graduate School of Medical Sciences. He is an elected Fellow of the American Academy of Microbiology, the International Society for Vaccines, and the College of Physicians of Philadelphia.  He is a former Trustee of the National Foundation for Infectious Diseases and served as a member of the National Preparedness & Response Science Board, an advisory committee to the U.S. Secretary of Health and Human Services.

  • Emilio A. Emini, Ph.D.

    Seminar Speaker

  • , ,